Condition

Critical Limb Ischemia

ClinicalTrials.gov condition label

Clinical trials20

Recruiting1

Common interventions25

Lead sponsors shown15

Clinical trials

20 shown

Additional Hyperbaric Oxygen After Lower Extremity AmputationNCT03594344 · 2018-07-04

RECRUITING

Diagnostic Tools to Establish the Presence and Severity of Peripheral Arterial Disease in People With DiabetesNCT05009602 · 2022-03-14

COMPLETED

Autologous Fat Grafting in the Treatment of Critical Limb IschaemiaNCT04746599 · 2021-01-01

UNKNOWN

Trial to Assess Chelation Therapy in Critical Limb IschemiaNCT03982693 · 2019-03-19

ACTIVE_NOT_RECRUITING

TEsting for Arterial Disease in Diabetes (TrEAD) StudyNCT04058626 · 2019-03-04

COMPLETED

Laboratory, Cellular and Molecular Determinants of Clinical Success in Diabetic Patients With Critical Limb IschemiaNCT03636867 · 2018-08-07

COMPLETED

RECCORD (Recording Courses of Vascular Diseases) RegistryNCT03448029 · 2018-01-01

UNKNOWN

N-Acetyl-Cysteine (NAC) for Healing of Amputation Stumps in the Setting of DiabetesNCT03253328 · 2017-03-01

COMPLETED

Effectiveness and Safety of Adipose-Derived Regenerative Cells for the Treatment of Critical Lower Limb IschemiaNCT02864654 · 2016-07-01

UNKNOWN

Plerixafor in Diabetic Wound HealingNCT02790957 · 2016-06-01

TERMINATED

Autologous Peripheral Blood Mononuclear Cells in Diabetic Foot Patients With No-option Critical Limb IschemiaNCT04255004 · 2014-01-01

COMPLETED

Registry of First-line Treatments in Patients With Critical Limb IschemiaNCT01877252 · 2013-01-01

COMPLETED

Safety and Efficacy Study of Urokinase for the Treatment of Diabetic Foot Syndrome and Critical Limb IschemiaNCT01638585 · 2011-06-01

TERMINATED

Umbilical Cord Mesenchymal Stem Cells Injection for Diabetic FootNCT01216865 · 2011-01-01

UNKNOWN

Register for Patients With Diabetic Foot Syndrome and Critical Limb IschemiaNCT01599442 · 2010-06-01

TERMINATED

Safety Study of MultiGeneAngio in Patients With Chronic Critical Limb IschemiaNCT00956332 · 2010-02-01

UNKNOWN

A Clinical Trial on Diabetic Foot Using Peripheral Blood Derived Stem Cells for Treating Critical Limb IschemiaNCT00922389 · 2009-07-01

UNKNOWN

Diabetic Foot and Vascular Progenitor CellsNCT01269580 · 2009-02-01

UNKNOWN

Feasibility of Peripheral Angioplasty in Type D TASCII LesionsNCT01297387 · 2009-01-01

COMPLETED

Autologous Bone Marrow Stem Cell Transfer in Patients With Chronical Critical Limb Ischemia and Diabetic FootNCT01232673 · 2008-10-01

COMPLETED

Common interventions

Ankle Brachial Pressure Index (ABPI)DIAGNOSTIC_TEST2Podiatry Ankle Duplex scan (PAD-scan)DIAGNOSTIC_TEST2Standard TherapyDRUG2Toe Brachial Pressure Index (TBPI)DIAGNOSTIC_TEST2Active Arm N-acetyl cysteine (NAC)DRUG1ADRC injectionPROCEDURE1ADRC isolationOTHER1Audible handheld DopplerDIAGNOSTIC_TEST1Autologous Fat GraftingPROCEDURE1BMAC application in Critical Limb IschemiaPROCEDURE1data and specimen collectionOTHER1Duplex AssistDIAGNOSTIC_TEST1Edetate DisodiumDRUG1Endovascular revascularizationPROCEDURE1Exercise Ankle Brachial Pressure Index (ABPI)DIAGNOSTIC_TEST1G-CSFDRUG1Hyperbaric oxygen therapyPROCEDURE1LiposuctionPROCEDURE1MultiGeneAngioBIOLOGICAL1No vascular interventionOTHER1Pall Celeris System, point of care device for human cell therapyDEVICE1PlaceboDRUG1PlaceboOTHER1Placebo ArmDRUG1PlerixaforDRUG1

Leading sponsors

GWT-TUD GmbH2IRCCS Multimedica2Beike Biotech India Pvt.ltd1Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation1Deutsche Gesellschaft für Angiologie, Gesellschaft für Gefäßmedizin e.V.1Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico1Gian Paolo Fadini1Imperial College Healthcare NHS Trust1Imperial College London1Maria Cecilia Hospital1Mt. Sinai Medical Center, Miami1MultiGene Vascular Systems Ltd.1Oslo University Hospital1Ospedale San Donato1Qingdao University1

Trial status mix

COMPLETED8

UNKNOWN7

TERMINATED3

ACTIVE_NOT_RECRUITING1

RECRUITING1

Phase mix

PHASE26

PHASE14

NA3

PHASE32

EARLY_PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.